Vaccine
development
service

Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine Bilthoven, the Netherlands, 5 January 2022 – Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against infectious diseases, today…

• Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteins
• No use of mRNA or vector technology
• Better and direct immunization of mucosa against multiple corona viruses
• Intravacc focuses on preclinical and process development research and GMP vaccine production
• Financing of clinical trial study made possible in part by Dutch governmental body Top Consortium for Knowledge and Innovation (TKI)

Intravacc launches hybrid business model to drive innovation and growth Bilthoven, the Netherlands, 16 September 2021 – Intravacc, a global leader in translational research and the development of vaccines against infectious diseases and therapeutic vaccines, today launches its new hybrid…

• Hybrid model: CDMO services and development of a proprietary vaccine pipeline
• Intravacc will also put emphasis on the therapeutic vaccine market
• Intravacc’s proprietary vaccine portfolio will mainly focus on intranasal administration
• Intravacc launches promotional campaign, supporting the funding of a phase I clinical trial with the Avacc 10 nasal spray vaccine

Intravacc’s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China Bilthoven, the Netherlands, 20 July 2021 – Intravacc, a world leader in translational research and development of vaccines for infectious diseases and therapeutics, today announced that the…

• Sabin-IPV polio vaccine developed by Intravacc contributes to the eradication of polio
• Sinovac’s polio vaccine (sIPV) receives market authorization from the NMPA in China
• Intravacc’s cell technology also used for the development of Sinovac’s Covid-19 vaccine that was introduced on the market recently and is currently under rolling review by EMA